Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia

Clinical trial NCT04364269 · COMPLETED

Trial details

NCT number: NCT04364269
Sponsor: Vifor (International) Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Beta-Thalassemia Non-transfusion-dependent Thalassemia

Start date: 2020-06-11
Primary completion: 2021-10-11
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.